Pages that link to "Q36243852"
Jump to navigation
Jump to search
The following pages link to Green tea halts progression of cardiac transthyretin amyloidosis: an observational report (Q36243852):
Displaying 37 items.
- The Prevalence and Management of Systemic Amyloidosis in Western Countries (Q26740436) (← links)
- Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure (Q26776120) (← links)
- Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis (Q26776496) (← links)
- Infiltrative Cardiomyopathies (Q26798533) (← links)
- Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins (Q28079722) (← links)
- Novel drugs targeting transthyretin amyloidosis (Q34400138) (← links)
- An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis (Q34428314) (← links)
- Targeting protein aggregation for the treatment of degenerative diseases (Q36235980) (← links)
- Clearance of extracellular misfolded proteins in systemic amyloidosis: experience with transthyretin (Q38028212) (← links)
- Light chain amyloidosis 2012: a new era. (Q38072108) (← links)
- Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation (Q38217070) (← links)
- Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols. (Q38270777) (← links)
- Emerging treatments for amyloidosis (Q38282186) (← links)
- Emerging Advances in the Management of Cardiac Amyloidosis (Q38587648) (← links)
- Novel strategies for the diagnosis and treatment of cardiac amyloidosis. (Q38614967) (← links)
- Natural product-based amyloid inhibitors. (Q38733078) (← links)
- Newer Therapies for Amyloid Cardiomyopathy (Q38920614) (← links)
- Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis (Q39217713) (← links)
- The Effect of (-)-Epigallo-catechin-(3)-gallate on Amyloidogenic Proteins Suggests a Common Mechanism (Q40818380) (← links)
- Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study (Q42162484) (← links)
- Transthyretin chemical chaperoning by flavonoids: Structure-activity insights towards the design of potent amyloidosis inhibitors. (Q46693222) (← links)
- Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study (Q50437078) (← links)
- Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor (Q51689510) (← links)
- Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin (Q56422855) (← links)
- Dietary curcumin counteracts extracellular transthyretin deposition: Insights on the mechanism of amyloid inhibition (Q60595536) (← links)
- Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis (Q64093591) (← links)
- [What gnaws at the heart and gets on the nerves] (Q64360865) (← links)
- [Hereditary transthyretin amyloidosis] (Q87577739) (← links)
- Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study (Q89036532) (← links)
- Healthy Effects of Plant Polyphenols: Molecular Mechanisms (Q89762207) (← links)
- Transthyretin cardiac amyloidosis: an update on diagnosis and treatment (Q90274848) (← links)
- Emerging therapies in transthyretin amyloidosis - a new wave of hope after years of stagnancy? (Q92486932) (← links)
- Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy (Q92489479) (← links)
- Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis (Q92885213) (← links)
- WITHDRAWN: [Treatment of AL amyloidosis] (Q93074047) (← links)
- Diagnosis and treatment of transthyretin-related amyloidosis cardiomyopathy (Q98161293) (← links)
- Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence-Based Recommendations (Q99618867) (← links)